APA (7th ed.) Citation

J, B., D, B., J, H., V, D., Z, K., A, G., . . . P, M. (2020). The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study. United European gastroenterology journal, 8(8), 949. https://doi.org/10.1177/2050640620945949

Chicago Style (17th ed.) Citation

J, Burisch, et al. "The Use of 5-aminosalicylate for Patients with Crohn's Disease in a Prospective European Inception Cohort with 5 Years Follow-up - an Epi-IBD Study." United European Gastroenterology Journal 8, no. 8 (2020): 949. https://doi.org/10.1177/2050640620945949.

MLA (9th ed.) Citation

J, Burisch, et al. "The Use of 5-aminosalicylate for Patients with Crohn's Disease in a Prospective European Inception Cohort with 5 Years Follow-up - an Epi-IBD Study." United European Gastroenterology Journal, vol. 8, no. 8, 2020, p. 949, https://doi.org/10.1177/2050640620945949.